This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

Evolution 1998-2002 of the antidepressant consumption in France, Germany and the United Kingdom

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Nathalie Grandfils () (IRDES institut for research and information in health economics)
Catherine Sermet () (IRDES institut for research and information in health economics)

Additional information is available for the following registered author(s):

Abstract

The aim of this paper is to compare the evolution of antidepressant consumption in France, Germany and the United Kingdom between 1998 and 2002. Commercial databases (IMS Health) have been used in conjunction with administrative data (PACT for the UK, GKV for Germany and Afssaps for France) to estimate antidepressant consumption in Daily Defined Doses. The main results are: (1) Antidepressant consumption has increased significantly over the last decade in France (x2), Germany (x2.4) and the UK (x3.8); (2) SSRIs are the most heavily consumed drugs in France (67%) and the UK (60%); (3) Germany is distinguished by an overall level of antidepressant consumption twice as low as the other two countries and a relatively low use of SSRI antidepressants (31%), in favour of TCAs. In conclusion, the combined use of administrative and commercial data is possible for an evaluation of the volume of consumption. This study sheds both medical and economic light on the differences in both the level and structure of consumption in these three countries.

Download Info
To download:

If you experience problems downloading a file, check if you have the proper application to view it first. Information about this may be contained in the File-Format links below. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://www.irdes.fr/EspaceAnglais/Publications/WorkingPapers/DT21EvoluAntidepressantConsumFranceGermanyUk.pdf
File Format: application/pdf
File Function: First version, 2009
Download Restriction: no

Publisher Info
Paper provided by IRDES institut for research and information in health economics in its series Working Papers with number DT21.

Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF
Length: 17 pages
Date of creation: Feb 2009
Date of revision: Feb 2009
Handle: RePEc:irh:wpaper:dt21

Contact details of provider:
Postal: 10 rue Vauvenargues, 75018 Paris
Phone: 33 1 53 93 43 00
Fax: 33 1 53 93 43 50
Web page: http://www.irdes.fr
More information through EDIRC

For technical questions regarding this item, or to correct its listing, contact: (Jacques Harrouin).

Related research
Keywords: antidepressant consumption; SSRI; France; UK; Germany;

Find related papers by JEL classification:
I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology

This paper has been announced in the following NEP Reports:

Statistics
Access and download statistics

Did you know? IDEAS uses the data collected within the RePEc project, the largest online bibliographic database in Economics.

This page was last updated on 2009-11-10.

This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.